Electromed, Inc. (NYSE:ELMD) Q1 2025 Earnings Conference Call November 12, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Hello, and welcome to the Electromed First Quarter 2025 Earnings Conference Call. All participants will be in listen-only mode. [Operator Instructions] As a reminder, this conference is ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . | --- | --- | --- | |----------------------------------------------------------------------------------------------------------------------------------- ...

Exhibit 99.1 Electromed, Inc. Announces Fiscal 2025 First Quarter Financial Results Electromed delivers eighth consecutive quarter of year-over-year revenue and profit growth, while continuing to invest in strategic growth initiatives NEW PRAGUE, Minn.--(BUSINESS WIRE) -- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended September 30, 2024 ("Q1 FY 2025"). Q1 FY 2025 Financial Highlights ● ...

Electromed, Inc. (NYSE:ELMD) Q4 2024 Earnings Conference Call August 27, 2024 5:00 PM ET Company Participants Mike Cavanaugh - IR, Westwicke Partners James Cunniff - President, CEO & Director Bradley Nagel - CFO, Treasurer & Company Secretary Conference Call Participants Aaron Wukmir - Lake Street Capital Markets Operator Greetings, and welcome to the Electromed Fourth Quarter 2024 Earnings Call. At this time all participants are in a listen-only mode. A question-and-answer session will follow the formal pr ...

Electromed, Inc. Investor Presentation August 27, 2024 NYSE American: ELMD Innovation Leader in Airway Clearance Technologies Investor Presentation | 1 Forward Looking Statements Certain statements in this press release constitute forward-looking statements as defined in the US Private Securities Litigation Reform Act of 1995. Forward-looking statements can generally be identified by words such as "anticipate," "believe," "estimate," "expect," "intend," "may," "plan," "potential," "should," "will," and simi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☑ Annual Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Fiscal Year Ended June 30, 2024 or ☐ Transition Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 For the Transition Period From ________ to ________. Commission File number 001-34839 | --- | --- | --- | |---------------------------------------------|--------------------------------------------- ...

Exhibit 99.1 Electromed, Inc. Announces Record Fiscal Year 2024 Financial Results Record Q4 and full year financial results NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. ("Electromed") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ("Q4 FY 2024") and full year ("FY 2024") ended June 30, 2024. Q4 FY 2024 Financial Highlights ● Net revenues increased 9.0% to a record $14.8 million in Q4 FY 2024, from $13.6 million in ...

No, that's a great question. It's really -- our hospital market is a nascent market for us. Most of our resources are focused on the clinical sale. And that's mainly because the pulmonologists are the ones primarily who are Our results this year have been really in line with what our expectations had been. Our hospital business in the quarter was up substantially, and for the year, it's over 30% up over prior year. So we're getting good traction there, and we hope to continue that. But we only have a few re ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File No.: 001-34839 Electromed, Inc. (Exact Name of Registrant as Specified in its Charter) Minnesota 41-1732920 (State or other jurisdiction of ...

Exhibit 99.1 Electromed, Inc. Announces Record Revenue in Fiscal 2024 Third Quarter Growth initiatives drive record revenue NEW PRAGUE, Minn.--(BUSINESS WIRE)-- Electromed, Inc. (“Electromed”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results for the three months ended March 31, 2024 (“Q3 FY 2024”). Q3 FY 2024 Financial Highlights ● Net revenues increased 15% to a record $13.9 million in Q3 FY 2024, from $12.1 million in the third quarter of the p ...